Alexandre de Germay
Fortune : 2 M $ au 31/05/2026
Fortune : 2 M $ au 31/05/2026
Alexandre de Germay currently works at Pfizer Inc., as Chief International Commercial Officer & EVP from 2023.
Mr. de Germay also formerly worked at Laboratoires Majorelle SAS, as Co-Chief Executive Officer from 2021 to 2023 and Sanofi, as Senior Vice President & Global Head-Cardiovascular.
Mr. de Germay received his graduate degree from Université Sorbonne Paris Nord.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/03/2026 | 74 377 ( 0% ) | 2 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 15/12/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Laboratoires Majorelle SAS
Laboratoires Majorelle SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Directeur Général | 01/01/2023 |
| SANOFI | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Université Sorbonne Paris Nord
Université Sorbonne Paris Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laboratoires Majorelle SAS
Laboratoires Majorelle SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national